Michael Kolodziej, MD, and Jeffrey C. Ward, MD, explain why payment reform in oncology is far more complicated than it may seem. View Now >>
In this segment, Mark A. Socinski, MD; Mary Jo Fidler, MD; Roy S. Herbst, MD, PhD; and Geoffrey R. Oxnard, MD, discuss options for upfront therapy in EGFR-positive non-small cell lung cancer, including gefitinib and erlotinib. View Now >>
Featured Program
Giants of Cancer Care
The OncLive News Network updates viewers on breaking news, clinical trial results, FDA approvals, and offers an inside look into leading cancer centers and clinical trials. View Now >>
Highlights from the 2014 ASH Annual Meeting
Laura Jones recaps major findings from the 2015 ASCO Annual Meeting, including phase III findings for new treatments in melanoma, chronic lymphocytic leukemia, lung cancer, breast cancer, and multiple myeloma.
View Now

Most Popular Right Now
$auto_registration$